Alternatives to PAIN Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Alternatives to PAIN Act (H.R. 7142) is a health-related bill introduced in the 118th Congress. The bill was referred to the Subcommittee on Health on December 17, 2024, but no official summary or full text is publicly available. The bill's title suggests it aims to address alternatives to pain management, potentially focusing on non-opioid or non-pharmacological approaches. However, without the full text or summary, the specific provisions, goals, or mechanisms of the bill cannot be determined.
H.R. 7142, the Alternatives to PAIN Act, is a health-focused bill that has not advanced beyond subcommittee referral and lacks publicly available details, limiting analysis of its content or impact.
- The bill is titled 'Alternatives to PAIN Act' and relates to the health policy area.
- It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health on December 17, 2024.
- The bill status is marked as 'Failed / Expired,' indicating it did not progress to enactment during the session.
Potential beneficiaries could include patients seeking alternative pain management options, healthcare providers involved in pain treatment, and health agencies overseeing pain management policies. However, specific beneficiaries cannot be identified due to lack of detailed bill text.
Without the full bill text, potential concerns include unknown implementation challenges, funding requirements, regulatory authority, oversight mechanisms, and possible tradeoffs between alternative pain treatments and existing standards of care.
The bill was introduced in the 118th Congress and referred to a relevant subcommittee but did not advance further, resulting in failure or expiration. This reflects the legislative process where many bills do not progress beyond initial referral stages. The health policy area often involves complex stakeholder interests and regulatory considerations.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
If enacted, the bill could influence healthcare practices by promoting alternative pain management strategies, potentially affecting opioid prescription rates and healthcare costs. However, due to lack of text, these effects remain speculative based on the bill's title alone.
The absence of a bill summary and full text limits transparency and public accountability. Monitoring the legislative process for such bills is important to ensure stakeholders have access to detailed information for informed debate and oversight. The bill's failure to advance highlights the need for tracking legislative progress and understanding barriers to policy adoption.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.